- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05099185
Water Soluble Vitamins and Trace Elements Loss in Hemodiafiltration Patients (VITAFLUX)
Measurement of Water-soluble Vitamins and Trace Elements Loss With Maintenance Post-dilution Haemodiafiltration Patient
End stage renal disease is a severe pathology in which some toxic waste and an excessive amount of water can accumulate in the human body with life threatening consequences. Maintenance hemodialysis is one of the possible treatment for this disease.
Hemodialysis filter the blood through a membrane according to a dialysis bath and so can be able to purify the blood of the toxic waste.
Otherwise, since the 1980s, the investigator know that patient in maintenance hemodialysis can have some deficiency in water soluble vitamins and trace elements. Mechanisms of the deficiency are multiple (a decreased of food intake, a diminution of the appetite, digestive malabsorption du to medics and comorbidities and loss in hemodialysis).
Impact of this deficiency have an important impact on vital prognosis for these patients. These nutrients are essential for AND synthesis, mechanism of inflammation, cells membranes synthesis, etc. DOPPs study in 2004 have shown a decreased of 16% in the mortality within 4 years with supplemented patients. Also, since this study, international recommendations were wrote in 2009, then in 2020, in order to supplement in vitamins and trace elements patients in maintenance conventional hemodialysis.
Despite these recommendations, some supplementary efforts are necessary, especially since online hemodiafiltration, a new process, is widely available and used in particular in Europe. This process combines 2 phenomena, diffusion and convection, through high-flux membranes. This process can remove a large quantity of molecule present in blood and especially the middle-molecule. In return, a more important quantity of water soluble vitamins and oligo-elements could be removed by this technique.
Also, the investigator would like to measure this loss of vitamins and trace-elements in patients with maintenance online post-dilution hemodiafiltration process with dialysate sample and blood concentrations measured (usual patient monitoring) during the session.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Pierre-Bénite, France, 69310
- Centre Hospitalier Lyon Sud
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Maintenance hemodialysis more than 3 months
- 3 sessions per week during 4 hours
- Hemodiafiltration process used with this patient on Lyon Sud Hospital
- Flow of the vascular access > 300 mL/min at least
- Age > 18 years
- Patient able to understand the study's goal
Exclusion Criteria:
- Active infectious or inflammatory disease
- Active malignant disease
- Intestinal malabsorptive disease
- Polysulfone's dialysis membrane allergy
- Patient under guardianship and judicial protection
- Pregnant and breastfeeding woman
- Opposition to the study
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Maintenance online post-dilution hemodiafiltration patients
Maintenance hemodialysis patients who undergo hemodialysis 3 times per week with online post-dilution hemodiafiltration process
|
We would like to measure water-soluble vitamins (B1, B6, B9, B12, C) and trace elements (zinc, selenium) in blood and dialysate for the patients treated by online post-dilution hemodiafiltration patients.
There measures on blood are done systematically during the half-yearly report of our patients in our hemodialysis center.
Only results are collect for the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of the blood concentrations measured in vitamins and trace elements before and after the hemodialysis session by the post-dilution HDF technique during the half-yearly assessment (usual patient follow-up).
Time Frame: Day 1
|
We would like to measure the concentrations of water-soluble vitamins and trace elements in dialysate by collecting 1% of this by Theraflux® device, and compare to the blood concentration collecting during the half-yearly report at the beginning then at the end of one hemodialysis session with online post-dilution hemodiafiltration session.
|
Day 1
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Etienne NOVEL-CATIN, MD, Nephrology department
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL21_0491
- 2021-A01241-40 (Other Identifier: ID-RCB)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Hemolysis
-
Hadassah Medical OrganizationUnknown
-
Guy's and St Thomas' NHS Foundation TrustUniversity of OxfordNot yet recruitingHemolysis Neonatal
-
National Institutes of Health Clinical Center (CC)CompletedIsoagglutinin-Mediated Hemolysis | Probiotic ToxicityUnited States
-
Cedars-Sinai Medical CenterWithdrawnAcute Decompensated Heart Failure | Hemolysis IntravascularUnited States
-
Aswan UniversityRecruitingObstetric Hemostasis | Intravascular Hemolysis | Major Obstetric Hemorrhage | Manual Syringing Transfusion | Pneumatic Pressure Bag TransfusionEgypt
-
CHU de ReimsUnknownProspective Studies | Chronic Hemolysis | VKA | Anticoagulants / Administration & Dosage | Coated Materials | Biocompatible | Heparin / Administration & Dosage | Membranes Artificial | Renal Dialysis / Methods | Renal Insufficiency / TherapyFrance
-
Hanyang UniversityCompletedChronic Kidney Diseases | Hemolysis
-
Universidad Politecnica de MadridUniversidad Europea de Madrid; Fundación Renal Iñigo Alvarez De ToledoCompleted
-
Radiometer Medical ApSBispebjerg HospitalRecruiting
-
Johns Hopkins UniversityTerminatedEnd Stage Renal Disease | Hemolysis | Arteriovenous GraftUnited States
Clinical Trials on Water-soluble vitamins and trace elements measures
-
University Hospital, ToulouseRecruiting
-
Graminex LLCKGK Science Inc.CompletedUrinary IncontinenceCanada
-
Rockwell Medical Technologies, Inc.CompletedEnd-Stage Renal Disease (ESRD)United States, Canada
-
Chung Shan Medical UniversityCompletedPediatric Dilated CardiomyopathyTaiwan
-
DoubleGood ABLund UniversityCompletedType 2 Diabetes Mellitus | Metabolic Syndrome | Postprandial HyperglycemiaSweden
-
Institute of Oncology LjubljanaRecruitingTrace Element DeficiencySlovenia
-
Centre Hospitalier Universitaire VaudoisCompletedCritical Illness | Burn Injury | Nutritional Deficiency | Trace Element DeficiencySwitzerland
-
Fundació Institut Germans Trias i PujolGermans Trias i Pujol HospitalCompleted
-
Chang Gung Memorial HospitalCompletedSepsis | Critical Illness | Acute Abdomen | Selenium Deficiency | Trace Element DeficiencyTaiwan